stockrowAngioDynamics, Inc. (ANGO) vs Pro-Dex, Inc. (PDEX)
- AngioDynamics, Inc. ANGO 11.67 −4.73%
- Pro-Dex, Inc. PDEX 61.57 −2.95%
AngioDynamics, Inc. and Pro-Dex, Inc. are both Medical Instruments & Supplies companies. AngioDynamics, Inc. is the larger, with a market value of $496.7M against $195.8M — 2.5× the size. AngioDynamics, Inc. has negative trailing earnings, so its P/E is not meaningful; Pro-Dex, Inc. trades at 16.4×. Pro-Dex, Inc. grew revenue faster over the last twelve months: 13.3% against 8.20%. Pro-Dex, Inc. has the higher net margin (15.1% vs −10.1%) and the higher return on invested capital (17.2% vs −17.6%). Across the 19 metrics below, Pro-Dex, Inc. leads on 14 and AngioDynamics, Inc. on 5.
Valuation
Profitability
| Metric | ANGO | PDEX | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 55.65% | 32.45% | 53.60% |
| Operating margin | (11.24%) | 16.84% | 1.97% |
| Net margin | (10.12%) | 15.12% | 0.00% |
| Free cash flow margin | 0.44% | 13.43% | 2.36% |
| Return on equity | (19.21%) | 26.48% | 0.00% |
| Return on assets | (12.98%) | 17.08% | 0.00% |
| Return on invested capital | (17.58%) | 17.22% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack